GlassScriptPhysician profile
Siddharth Reddy
NPI 1760800338
$20,071.76
in general payments reported to CMS, 2019-2025
29 companies · $3,303 in 2025
The $3,303 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $2,475 · 2021: $1,676 · 2022: $4,352 · 2023: $5,008 · 2024: $2,710 · 2025: $3,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,612 · Food and Beverage: $4,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,611.63 |
| Food and Beverage | $4,409.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,726.57 | 2022-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $3,625.58 | 2019-2025 | General - Therapies, Watchman Flx, Ingevity Mri |
| Abiomed | $3,555.07 | 2020-2025 | Impella |
| Medtronic Vascular, INC. | $1,679.52 | 2020 | |
| Bard Peripheral Vascular, INC. | $1,476.83 | 2022-2023 | Venovo, Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $1,305.77 | 2021-2024 | Turbohawk |
| Abbott Laboratories | $531.51 | 2019-2024 | Mitraclip, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $498.89 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $348.96 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $313.45 | 2020-2025 | Farxiga, Wainua |
| Amgen INC. | $296.22 | 2019-2024 | Repatha |
| Cardiovascular Systems INC. | $235.24 | 2020-2023 | Diamondback Coronary |
| Biotronik INC. | $227.90 | 2025 | Amvia Edge, Biomonitor, Pamira |
| Novartis Pharmaceuticals Corporation | $221.19 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $210.42 | 2020-2025 | Camzyos, Eliquis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.63 | 2020-2025 | Lifevest |
| Philips North America LLC | $152.33 | 2019-2025 | Azurion 7 M20 |
| Angiodynamics, INC. | $120.71 | 2021-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Janssen Pharmaceuticals, INC | $80.84 | 2023 | Xarelto |
| Chiesi USA, INC. | $75.13 | 2021 | |
| Scpharmaceuticals INC. | $35.59 | 2025 | |
| Heartflow, INC. | $32.58 | 2024-2025 | |
| Pfizer INC. | $30.42 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.97 | 2021-2023 | Jardiance |
| W. L. Gore & Associates, INC. | $21.30 | 2025 | Gore Cardioform Septal Occluder |
| Lantheus Medical Imaging, INC. | $20.06 | 2019 | |
| Novo Nordisk INC | $18.88 | 2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $16.58 | 2023 | Verquvo |
| Lifenet Health | $14.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siddharth Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.